Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Jan;10(1):21-8.
doi: 10.1016/s1074-7613(00)80003-5.

An antiviral mechanism of nitric oxide: inhibition of a viral protease

M Saura  1 , C Zaragoza, A McMillan, R A Quick, C Hohenadl, J M Lowenstein, C J Lowenstein
Affiliations

An antiviral mechanism of nitric oxide: inhibition of a viral protease

M Saura et al. Immunity. 1999 Jan.

Abstract

Although nitric oxide (NO) kills or inhibits the replication of a variety of intracellular pathogens, the antimicrobial mechanisms of NO are unknown. Here, we identify a viral protease as a target of NO. The life cycle of many viruses depends upon viral proteases that cleave viral polyproteins into individual polypeptides. NO inactivates the Coxsackievirus protease 3C, an enzyme necessary for the replication of Coxsackievirus. NO S-nitrosylates the cysteine residue in the active site of protease 3C, inhibiting protease activity and interrupting the viral life cycle. Substituting a serine residue for the active site cysteine renders protease 3C resistant to NO inhibition. Since cysteine proteases are critical for virulence or replication of many viruses, bacteria, and parasites, S-nitrosylation of pathogen cysteine proteases may be a general mechanism of antimicrobial host defenses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The NO Donor SNAP Inhibits CVB3 Replication HeLa cells were infected with CVB3 at a multiplicity of infection of 10. SNAP (200 μM) was added at various times after infection as indicated. The amount of CVB3 after 10 hr of infection was measured by the plaque assay. To one set of infected cells (C), 200 μM AP was added 1 hr after infection. To another set of cells (-1), SNAP was added 1 hr before infection. n = 3 ± SD.
Figure 2
Figure 2
Figure 2. NO Inhibits Proteolysis of CVB3 Polypeptide 2BC in Infected Cells (A) Exogenous NO donor SNAP inhibits proteolysis of CVB3 polypeptide. HeLa cells were infected with CVB3 at a multiplicity of infection of 10. After 1 hr, 200 μM of SNAP (+) or AP (-) was added, and after 3.5 hr guanidine was added to inhibit new viral RNA synthesis. HeLa cells were harvested at various times indicated after guanidine treatment. Cell lysates were fractionated by SDS-PAGE and immunoblotted with an antibody to CVB3 polypeptide 2C. These experiments were repeated twice with similar results. (B) Endogenous NO from activated macrophages inhibits proteolysis of CVB3 polypeptide. HeLa cells were infected with CVB3 at a multiplicity of infection of 10. After 1 hr, plastic inserts containing resting (R) or LPS/IFN-stimulated (S) macrophages were added to the wells containing infected HeLa cells. Some cultures were also treated with the NOS inhibitor NAME (0–10 mM). Cells were harvested 5 hr after infection and cell lysates analyzed for CVB3 polypeptide 2C as above. This experiment was repeated five times with similar results. (C) LPS or IFN do not directly affect CVB3 replication. HeLa cells were infected with CVB3 at a multiplicity of infection of 10. After 1 hr, LPS or IFN or media alone was added to the wells containing infected HeLa cells. Some cultures were also treated with the NOS inhibitor NAME (0–10 mM). Cells were harvested 5 hr after infection and cell lysates analyzed for CVB3 polypeptide 2C as above.
Figure 3
Figure 3
NO Inhibits Cleavage of a Viral Target by Purified 3Cpro (A) 3Cpro was expressed in bacteria and purified. Bacterial lysates were subjected to SDS-PAGE: lane 1, noninduced bacteria; lane 2, bacteria induced with IPTG; lane 3, high-speed supernatant of induced bacteria; lane 4, flow-through from a Ni+ column; lanes 5–9, sequential column washes with 10 mM imidazole; and lanes 10–13, fractions from a Ni+ column eluted with 500 mM imidazole. (B) The purified fusion protein GST-3B-3CT, which contains an authentic 3Cpro cleavage site, was incubated with buffer, purified 3Cpro, or 3Cpro with the control compound AP, or the NO donor SNAP, or SNAP and DTT. The reaction mixture was analyzed by immunoblot with an antibody to GST and quantitated by densitometry. n = 3 ± SD, and * p < 0.05. (C) The cleavage experiment was then repeated using spermine NONOate (SP-NO) as an NO donor or its control compound spermine (SP). n = 3 ± SD, and * p < 0.05.
Figure 4
Figure 4
NO Inhibits 3Cpro Cleavage of Luciferase (A) Purified 3Cpro was added to luciferase, which contains a 3Cpro consensus cleavage motif, and the activity of luciferase remaining at various times was assayed using a luminometer. n = 3 ± SD. (B) Increasing amounts of 3Cpro were added to luciferase for 3 hr, and the amount of luciferase assayed as above. n = 3 ± SD. (C) Luciferase was incubated alone, or in the presence of 3Cpro with the following additions: the control compound AP, the NO donor SNAP, SNAP and DTT, the control compound spermine (SP), the NO donor spermine NONOate (SP-NO), or spermine NONOate and DTT. n = 3 ± SD.
Figure 5
Figure 5
NO Eliminates a Sulfhydryl Group from 3Cpro and Nitrosylates 3Cpro Purified 3Cpro was incubated with AP, SNAP, spermine, or spermine NONOate. (A) Analysis of the 3Cpro sulfhydryl group. Treated 3Cpro was incubated with an excess of 5,5 dithiobis(2-nitrobenzoate) (DNTB) and its absorption measured at 412 nm. n = 4 ± SD. (B) Nitrosylation of the 3Cpro active site Cys147. 3Cpro was exposed to NO donors or their controls, then incubated with HgCl2, and the amount of nitrite released was measured by the Griess reaction. n = 4 ± SD.
Figure 6
Figure 6
Mutation of the 3Cpro Active Site Cys147 Renders 3Cpro Resistant to NO A mutant 3Cpro with serine substituted for cysteine at amino acid residue 147 was purified from bacteria. Wild-type 3Cpro (1 μg/ml) and mutated 3Cpro (5 μg/ml) were incubated for 3 hr with luciferase and AP, SNAP, or SNAP and DTT, and the activity of luciferase assayed in a luminometer. n = 3 ± SD, repeated twice with similar results.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng Y.M, Dietzschold B, Maeda H. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA. 1996;93:2448–2453. - PMC - PubMed
    1. Akarid K, Sinet M, Desforges B, Gougerot-Pocidalo M.A. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J. Virol. 1995;69:7001–7005. - PMC - PubMed
    1. Aldape K, Huizinga H, Bouvier J, McKerrow J. Naegleria fowleri: characterization of a secreted histolytic cysteine protease. Exper. Parasitol. 1994;78:230–241. - PubMed
    1. Babe L.M, Craik C.S. Viral proteases: evolution of diverse structural motifs to optimize function. Cell. 1997;91:427–430. - PubMed
    1. Bailly E, Jambou R, Savel J, Jaureguiberry G. Plasmodium falciparum: differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and Pepstatin A (aspartyl protease inhibitor) J. Protozool. 1992;39:593–599. - PubMed

Publication types

MeSH terms

LinkOut - more resources